Accolade to Announce Fiscal Third Quarter 2023 Financial Results
21 December 2022 - 12:00AM
Accolade, Inc. (NASDAQ: ACCD), a healthcare provider that serves
millions of members, today announced that it will release
fiscal third quarter 2023 financial results on Monday, January 9,
2023, after the market closes. In conjunction, the company will
host a conference call to review results at 4:30 p.m. E.T. on the
same day.
Conference Call Details
To Listen via Telephone: Pre-registration is required by the
conference call operator. Please pre-register by clicking here
(https://register.vevent.com/register/BIae7d2bb974dc4198bb9154f71b0b1945).
Upon registering, you will be emailed a dial-in number, direct
passcode and unique PIN.
To Listen via Internet: The conference call can be accessed via
a live audio webcast that will be available online at
http://ir.accolade.com .
Replay: A replay of the call will be available via webcast for
on-demand listening shortly after the completion of the call, at
http://ir.accolade.com.
About Accolade, Inc.
Accolade (Nasdaq: ACCD) provides millions of people and their
families with an exceptional healthcare experience that is
personal, data driven and value based to help every person live
their healthiest life. Accolade solutions combine virtual primary
care, mental health support and expert medical opinion services
with intelligent technology and best-in-class care navigation.
Accolade's Personalized Healthcare approach puts humanity back in
healthcare by building relationships that connect people and their
families to the right care at the right time to improve outcomes,
lower costs and deliver consumer satisfaction. Accolade
consistently receives consumer satisfaction ratings over 90%. For
more information, visit accolade.com.
Investor Contact:
Todd Friedman, Investor Relations, IR@accolade.com
Media Contact:
Media Inquiries, Media@accolade.com
Source:
Accolade
Accolade (NASDAQ:ACCD)
Historical Stock Chart
From Mar 2024 to Apr 2024
Accolade (NASDAQ:ACCD)
Historical Stock Chart
From Apr 2023 to Apr 2024